Shopping Cart
Remove All
Your shopping cart is currently empty
Linaprazan glurate inhibits both exogenously and endogenously stimulated gastric acid secretion and can be utilized in studies on gastrointestinal inflammatory diseases and peptic ulcer diseases.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $34 | - | In Stock | |
| 5 mg | $60 | - | In Stock | |
| 10 mg | $98 | - | In Stock | |
| 25 mg | $179 | - | In Stock | |
| 50 mg | $289 | - | In Stock | |
| 100 mg | $463 | - | In Stock |
| Description | Linaprazan glurate inhibits both exogenously and endogenously stimulated gastric acid secretion and can be utilized in studies on gastrointestinal inflammatory diseases and peptic ulcer diseases. |
| Molecular Weight | 480.56 |
| Formula | C26H32N4O5 |
| Cas No. | 1228559-81-6 |
| Smiles | Cc1nc2c(NCc3c(C)cccc3C)cc(cn2c1C)C(=O)NCCOC(=O)CCCC(O)=O |
| Relative Density. | 1.25 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||
| Solubility Information | DMSO: 4.37 mg/mL (9.09 mM), Sonication is recommended. | |||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (2.08 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||
Solution Preparation Table | ||||||||||||||||
DMSO
| ||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.